FLGT vs MDT · rev $156.5M vs P/E 21, rev $36.36B
Fulgent Genetics Inc (FLGT) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported FLGT revenue for 2026-06-30 was $156.5M. Net income was -$54.4M. FLGT currently screens at market cap $586.6M.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
FLGT currently screens at market cap $586.6M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the FLGT and MDT stock pages for the full models.
Not investment advice.